125 results on '"Gunawardane, Ruwanthi N."'
Search Results
2. Integrated intracellular organization and its variations in human iPS cells
3. Enhanced endogenous gene tagging in human induced pluripotent stem cells via AAV6-mediated donor delivery
4. A comprehensive analysis of gene expression changes in a high replicate and open-source dataset of differentiating hiPSC-derived cardiomyocytes
5. Incomplete-penetrant hypertrophic cardiomyopathy MYH7 G256E mutation causes hypercontractility and elevated mitochondrial respiration.
6. Automated human induced pluripotent stem cell culture and sample preparation for 3D live-cell microscopy
7. It’s time to incorporate diversity into our basic science and disease models
8. Characterization and Reconstitution of Drosophila γ-Tubulin Ring Complex Subunits
9. Xgrip109: A γ Tubulin-Associated Protein with an Essential Role in γ Tubulin Ring Complex (γTuRC) Assembly and Centrosome Function
10. Multi-scale models reveal hypertrophic cardiomyopathy MYH7 G256E mutation drives hypercontractility and elevated mitochondrial respiration
11. Supplementary Figure 3 from Transient Exposure to Quizartinib Mediates Sustained Inhibition of FLT3 Signaling while Specifically Inducing Apoptosis in FLT3-Activated Leukemia Cells
12. Data from Transient Exposure to Quizartinib Mediates Sustained Inhibition of FLT3 Signaling while Specifically Inducing Apoptosis in FLT3-Activated Leukemia Cells
13. Data from CEP-32496: A Novel Orally Active BRAFV600E Inhibitor with Selective Cellular and In Vivo Antitumor Activity
14. Supplementary Figure 4 from Transient Exposure to Quizartinib Mediates Sustained Inhibition of FLT3 Signaling while Specifically Inducing Apoptosis in FLT3-Activated Leukemia Cells
15. Supplementary Data 1 from CEP-32496: A Novel Orally Active BRAFV600E Inhibitor with Selective Cellular and In Vivo Antitumor Activity
16. Supplementary Table 2 from Transient Exposure to Quizartinib Mediates Sustained Inhibition of FLT3 Signaling while Specifically Inducing Apoptosis in FLT3-Activated Leukemia Cells
17. Supplementary Figure 1 from Transient Exposure to Quizartinib Mediates Sustained Inhibition of FLT3 Signaling while Specifically Inducing Apoptosis in FLT3-Activated Leukemia Cells
18. Supplementary Table 1 from Transient Exposure to Quizartinib Mediates Sustained Inhibition of FLT3 Signaling while Specifically Inducing Apoptosis in FLT3-Activated Leukemia Cells
19. Supplementary Figure 2 from Transient Exposure to Quizartinib Mediates Sustained Inhibition of FLT3 Signaling while Specifically Inducing Apoptosis in FLT3-Activated Leukemia Cells
20. Multi-scale models reveal hypertrophic cardiomyopathy MYH7 G256E mutation drives hypercontractility and elevated mitochondrial respiration
21. PDEF Promotes Luminal Differentiation and Acts as a Survival Factor for ER-Positive Breast Cancer Cells
22. MYC Regulation of a "Poor-Prognosis" Metastatic Cancer Cell State
23. AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)
24. Cell states beyond transcriptomics: Integrating structural organization and gene expression in hiPSC-derived cardiomyocytes
25. A comprehensive analysis of gene expression changes in a high replicate and open-source dataset of differentiating hiPSC-derived cardiomyocytes
26. Automated hiPSC culture and sample preparation for 3D live cell microscopy
27. Cell states beyond transcriptomics: integrating structural organization and gene expression in hiPSC-derived cardiomyocytes
28. Xgrip109: a gamma tubulin-associated protein with an essential role in gamma tubulin ring complex (gamma-TuRC) assembly and centrosome function
29. Purification and reconstitution of Drosophila γ-tubulin complexes
30. γ-Tubulin complexes and their role in microtubule nucleation
31. Fluorescent Gene Tagging of Transcriptionally Silent Genes in hiPSCs
32. Endogenous Protein Tagging in Human Induced Pluripotent Stem Cells Using CRISPR/Cas9
33. Scarless gene tagging of transcriptionally silent genes in hiPSCs to visualize cardiomyocyte sarcomeres in live cells
34. Systematic gene tagging using CRISPR/Cas9 in human stem cells to illuminate cell organization
35. Characterization and Reconstitution of Drosophila [Gamma]-Tubulin Ring Complex Subunits
36. Agonistic Human Antibodies Binding to Lecithin-Cholesterol Acyltransferase Modulate High Density Lipoprotein Metabolism
37. The high-resolution crystal structure of human LCAT
38. MYC regulation of a 'poor-prognosis' metastatic cancer cell state
39. 4-Quinazolinyloxy-diaryl ureas as novel BRAFV600E inhibitors
40. Transient Exposure to Quizartinib Mediates Sustained Inhibition of FLT3 Signaling while Specifically Inducing Apoptosis in FLT3-Activated Leukemia Cells
41. CEP-32496: A Novel Orally Active BRAFV600E Inhibitor with Selective Cellular and In Vivo Antitumor Activity
42. Discovery of Highly Potent and Selective Pan-Aurora Kinase Inhibitors with Enhanced in Vivo Antitumor Therapeutic Index
43. Identification of 1-(3-(6,7-Dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea Hydrochloride (CEP-32496), a Highly Potent and Orally Efficacious Inhibitor of V-RAF Murine Sarcoma Viral Oncogene Homologue B1 (BRAF) V600E
44. Abstract 3300: MYC regulation of a “poor prognosis” metastatic cancer cell state
45. AC220, a Potent, Selective, Second Generation FLT3 Receptor Tyrosine Kinase (RTK) Inhibitor, in a First-in-Human (FIH) Phase 1 AML Study.
46. Identification of N-(5-tert-Butyl-isoxazol-3-yl)-N′-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea Dihydrochloride (AC220), a Uniquely Potent, Selective, and Efficacious FMS-Like Tyrosine Kinase-3 (FLT3) Inhibitor
47. AC220 Is a Uniquely Potent and Selective Second-Generation FLT3 Inhibitor
48. Functional Proteomics Approach to Investigate the Biological Activities of cDNAs Implicated in Breast Cancer
49. Novel Role for PDEF in Epithelial Cell Migration and Invasion
50. Characterization of a New γTuRC Subunit with WD Repeats
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.